Stay updated on Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision entry (Revision: v3.3.3) was added to the history, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T08:11:14.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    New revision v3.3.2 was added and v3.3.1 was removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:11:54.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Revision history shows a new revision v3.3.1 added and a prior revision v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:31:30.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Added a new 'Study Status' column in the Study History table and increased the version count to 24; removed the government funding lapse notice.
    Difference
    0.9%
    Check dated 2025-11-17T06:39:43.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    New 'Study Status' entry appears in the record history (dated 2025-10-29, version 23). An earlier entry dated 2025-09-25 was removed.
    Difference
    0.4%
    Check dated 2025-11-03T01:12:05.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    11%
    Check dated 2025-10-05T10:15:52.000Z thumbnail image

Stay in the know with updates to Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.